KRAS phosphorylation regulates cell polarization and tumorigenic properties in colorectal cancer

Abstract

Oncogenic mutations of KRAS are found in the most aggressive human tumors, including colorectal cancer. It has been suggested that oncogenic KRAS phosphorylation at Ser181 modulates its activity and favors cell transformation. Using non-phosphorylatable (S181A), phosphomimetic (S181D) and phospho/dephosphorylatable (S181) oncogenic KRAS mutants, we analyzed the role of this phosphorylation to the maintenance of tumorigenic properties of colorectal cancer cells. Our data show that the presence of phospho/dephosphorylatable oncogenic KRAS is required for preserving the epithelial organization of colorectal cancer cells in 3D cultures, and for supporting subcutaneous tumor growth in mice. Interestingly, gene expression differed according to the phosphorylation status of KRAS. In DLD-1 cells, CTNNA1 was only expressed in phospho/dephosphorylatable oncogenic KRAS expressing cells, correlating with cell polarization. Moreover, lack of oncogenic KRAS phosphorylation leaded to changes in expression of genes related to cell invasion, such as SERPINE1, PRSS1,2,3 and NEO1, and expression of phosphomimetic oncogenic KRAS resulted in diminished expression of genes involved in enterocyte differentiation, such as HNF4G. Finally, the analysis, in a public data set of human colorectal cancer, of the gene expression signatures associated to phosphomimetic and non-phosphorylatable oncogenic KRAS suggests that this post-translational modification regulates tumor progression in patients.

Keratin 6A (KRT6A) promotes radioresistance, invasion, and metastasis in lung cancer via p53 signaling pathway

“…Ionizing [23,24]. After ionizing radiation, multiple pathways (mostly related to the cell cycle) are involved in maintaining genetic integrity [25]. Since the 1960s, scholars have AGING been studying the dependence of radiosensitivity on the pericellular period.…”

High expression of serine protease 2 (PRSS2) associated with invasion, metastasis, and proliferation in gastric cancer

“…The results showed that PRSS2, as an activator of matrix metalloproteinase (MMP), caused the degradation of peripheral collagen by activating interstitial collagenase. serine protease 2 has been proved to be associated with the development of tongue carcinoma, pancreatic carcinoma, colorectal carcinoma and ovarian carcinoma [24][25][26]. The high expression of serine protease 2 in pancreatic carcinoma is related to T phase.…”

The Role of CTNNA1 in Malignancies: An Updated Review

“…CTNNA1 is highly expressed in DLD-1 cells with phosphor-/ dephosphorylatable K-Ras, a necessary phenotype for maintaining epithelioid morphology and tumor growth, which may be associated with maintaining cell polarization and cell invasion. On the contrary, CTNNA1 expression decreases in cells with phosphomimetic or non-phosphorylatable K-Ras, and cell adhesion decreases accordingly [21].…”